Theriva Biologics

TOVXNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$10.133 M

$0.22 -1.78%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$23.7M

Loss-making

Shares outstanding

45,892,668

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#428BullFrog AIBFRG$10.9M
#429Lunai BioworksLNAI$10.9M
#430Theriva BiologicsTOVX$10.1M
#431Aspire BiopharmaASBP$10.0M
#432CytoMed TherapeuticsGDTC$9.71M

Where these numbers come from

Share counts and financials for Theriva Biologics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.